Orangekloud Technology에 대한 매도 수량은 투자자에게 Orangekloud Technology의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Orangekloud Technology (NASDAQ:ORKT) 주식, 공매도 수량 보고

Orangekloud Technology

Orangekloud Technology Inc is a company that operates through its subsidiaries provide IT consultancy services and distribution of related products and services. The Company also offers ERPs predominately in Singapore. It derives revenue from platform subscriptions, license and products and professional services.

Orangekloud Technology Inc. - Class A Ordinary Shares

Orangekloud Technology Inc

Keefe, Bruyette &amp; Woods analyst Aidan Hall reiterates SEI Inv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEIC#NASDAQ">SEIC</a>) with a Market Perform and raises the price target from $86 to $90.

News

Price Target

Reiteration

Analyst Ratings

SEIC

Keefe, Bruyette & Woods Reiterates Market Perform on SEI Inv, Raises Price Target to $90

JMP Securities analyst Devin Ryan maintains Stifel Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SF#NYSE">SF</a>) with a Market Outperform and raises the price target from $125 to $135.

JMP Securities Maintains Market Outperform on Stifel Financial, Raises Price Target to $135

Keefe, Bruyette &amp; Woods analyst Catherine Mealor reiterates Renasant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNST#NYSE">RNST</a>) with a Outperform and raises the price target from $45 to $46.

RNST

Keefe, Bruyette & Woods Reiterates Outperform on Renasant, Raises Price Target to $46

Keefe, Bruyette &amp; Woods analyst Kyle Voigt maintains Raymond James Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RJF#NYSE">RJF</a>) with a Market Perform and raises the price target from $170 to $177.

Keefe, Bruyette & Woods Maintains Market Perform on Raymond James Finl, Raises Price Target to $177

Trading Ideas

AMOD

Alpha Modus Holdings Shares Halted On Circuit Breaker To The Upside, Stock Now Up 140.3%

Keefe, Bruyette &amp; Woods analyst Wood Lay maintains Five Star (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSBC#NASDAQ">FSBC</a>) with a Market Perform and lowers the price target from $37 to $35.

FSBC

Keefe, Bruyette & Woods Maintains Market Perform on Five Star, Lowers Price Target to $35

JMP Securities analyst Karol Chmiel reiterates RenaissanceRe Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNR#NYSE">RNR</a>) from Market Perform to Market Perform.

JMP Securities Reiterates Market Perform on RenaissanceRe Holdingsto Market Perform

Scotiabank analyst Nat Schindler maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Sector Perform and raises the price target from $583 to $627.

Scotiabank Maintains Sector Perform on Meta Platforms, Raises Price Target to $627

Keefe, Bruyette &amp; Woods analyst Damon Delmonte reiterates First Busey (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BUSE#NASDAQ">BUSE</a>) with a Outperform and lowers the price target from $34 to $33.

BUSE

Keefe, Bruyette & Woods Reiterates Outperform on First Busey, Lowers Price Target to $33

Keefe, Bruyette &amp; Woods analyst Christopher O'Connell maintains Blue Foundry (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLFY#NASDAQ">BLFY</a>) with a Market Perform and lowers the price target from $11 to $10.

BLFY

Keefe, Bruyette & Woods Maintains Market Perform on Blue Foundry, Lowers Price Target to $10

Guidance

Altria Ceo William Gifford Says Altria Disagrees With ITC Decision In Juul Patent Case, Sees Juul's Patents As Invalid

CoStar Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGP#NASDAQ">CSGP</a>) has outperformed the market over the past 15 years by 9.86% on an annualized basis producing an average annual return of 22.09%. Currently, CoStar Gr has a market capitalization of $31.37 billion. 
Buying $1000 In CSGP: If an investor had bought $1000 of CSGP stock 15 years ago, it would be worth $20,096.81 today based on a price of $76.53 for CSGP at the time of writing.
<h3>CoStar Gr's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738247411_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CSGP

$1000 Invested In CoStar Gr 15 Years Ago Would Be Worth This Much Today

Keefe, Bruyette &amp; Woods analyst Christopher O'Connell maintains BCB Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCBP#NASDAQ">BCBP</a>) with a Market Perform and lowers the price target from $15 to $13.75.

BCBP

Keefe, Bruyette & Woods Maintains Market Perform on BCB Bancorp, Lowers Price Target to $13.75

JMP Securities analyst Devin Ryan maintains Raymond James Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RJF#NYSE">RJF</a>) with a Market Outperform and raises the price target from $175 to $190.

JMP Securities Maintains Market Outperform on Raymond James Finl, Raises Price Target to $190

Keefe, Bruyette &amp; Woods analyst Catherine Mealor maintains Atlantic Union Bankshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AUB#NYSE">AUB</a>) with a Market Perform and lowers the price target from $46 to $44.

Keefe, Bruyette & Woods Maintains Market Perform on Atlantic Union Bankshares, Lowers Price Target to $44

WIIM

CELZ

Creative Medical Technology Holdings shares are trading higher after the company announced initial data from the first cohort of its ongoing Phase 1/2 clinical trial of CELZ-201-DDT.

JMP Securities analyst Trevor Walsh maintains Planet Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PL#NYSE">PL</a>) with a Market Outperform and raises the price target from $4.5 to $6.5.

JMP Securities Maintains Market Outperform on Planet Labs, Raises Price Target to $6.5

Biotech

General

Creative Medical Technology Holdings Announces Initial Safety, Tolerability, and Efficacy Data From First Cohort In Phase 1/2 Trial Of CELZ-201-DDT

HarborOne Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HONE#NASDAQ">HONE</a>) announced its Q4 earnings on Thursday, January 30, 2025 at 08:21 AM.
Here's a breakdown of the earnings report.
<h3>Earnings</h3>
HarborOne Bancorp beat estimated earnings by 24.0%, reporting an EPS of $0.21 versus an estimate of $0.17.
Revenue was down $6.77 million from the same period last year.
<h3>Historical Earnings Summary</h3>
In the previous quarter, the company missed on EPS by $0.09, resulting in a 0.0% increase change in the share price the following day.
Here's a look at HarborOne Bancorp's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.19</td>
<td>0.17</td>
<td>0.11</td>
<td>0.15</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.10</td>
<td>0.18</td>
<td>0.17</td>
<td>0.09</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>32.17M</td>
<td>30.78M</td>
<td>29.23M</td>
<td>30.24M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>31.89M</td>
<td>31.35M</td>
<td>30.58M</td>
<td>38.60M</td>
</tr>
</tbody>
</table>

 Listen to the earnings announcement yourself by <a href="">clicking here</a>. 
To track all earnings releases for HarborOne Bancorp <a href="https://www.benzinga.com/quote/HONE/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

HONE

HarborOne Bancorp Earnings Review: Q4 Summary

Raymond James analyst Michael Rose maintains Veritex Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VBTX#NASDAQ">VBTX</a>) with a Strong Buy and lowers the price target from $32 to $31.

VBTX

Raymond James Maintains Strong Buy on Veritex Holdings, Lowers Price Target to $31

U.S. IPO Weekly Recap: Blockbuster IPO Week Sees Nearly $6 Billion Raised, Led By Cold Storage REIT Lineage

Orangekloud Technology files to sell 2.94M Class A ordinary shares for holders

Orangekloud (ORKT) Technology announced signing a partnership agreement with the Electronics Industries Training Centre, ELITC, a premier institute...

Orangekloud, ELITC enter partnership agreement

Orangekloud (ORKT) Technology reported that the Company last week introduced its AI-powered no-code application development platform at GITEX Globa...

Orangekloud introduces AI-powered no-code application development platform

09:35 EDT Orangekloud (ORKT) Technology Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking f...

Orangekloud Technology Inc trading resumes

09:30 EDT Orangekloud (ORKT) Technology Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time,...

Orangekloud Technology Inc trading halted, volatility trading pause

Orangekloud (ORKT) Technology announced the appointment of Toh Puay-Yong as CFO, replacing Ms. Shally Ang, who had held that position since Februar...

Orangekloud CFO Shally Ang resigns, Toh Puay-Yong to succeed

Netflix, Procter & Gamble, Johnson & Johnson Report Results In Holiday-Shortened Week

IPO Roundup: Toppoint, Venture Global and more

Maxim initiated coverage of Orangekloud (ORKT) with a Buy rating and $5 price target Published first on TheFly – the ultimate source for real-time,...

Orangekloud initiated with a Buy at Maxim

ACCD

ACTU

AGEN

AGRZ

ALXO

BLMZ

CANF

CRTG

DELL

DTSQU

DXST

FBGL

HWEP

INKT

ISRG

ITCI

JSPR

KURA

LINE

LPBBU

MSDL

MVRK

NFLX

NIPG

NXST

ODTX

ORKT

PGHL

PHOE

PICW

PYRO

QBTS

RGTI

SION

SKBL

SLGB

SLXN

SPHAU

TOPP

TSX:VG

TTAM

Press Releases

OrangeKloud Technology Inc. Announces Pricing of $13.1 Million Initial Public Offering

OrangeKloud Technology Inc. Announces Closing of $13.1 Million Initial Public Offering

Orangekloud Technology Inc. and Electronics Industries Training Centre (ELITC) Sign MOU to Enhance Workforce Skills and Drive Digital Transformation in Singapore

OrangeKloud partners with AI Singapore (AISG) to enhance No-Code App Building Technology with Artificial Intelligence

Orangekloud SaaS Solutions to be Distributed in South Africa via MOU Signed with JPJ Medical

Financing

Orangekloud Technology Signs S$1M Strategic Investment in Award-Winning Cybersecurity Firm, Evvo Labs

Orangekloud Technology Inc. and Electronics Industries Training Centre (ELITC) Ink Partnership Agreement to Empower Workforce Skills Development and Digital Transformation in Singapore

Orangekloud Introduces AI-Powered No-Code Application Development Platform at GITEX Global

Orangekloud Technology Appoints Mr. Toh Puay-Yong as Chief Financial Officer

Orangekloud Pioneers the Future of AI-Driven No-Code Development with Beta Launch of eMOBIQ® AI

Comments

Orangekloud Technology

매도 수량

Orangekloud Technology (NASDAQ:ORKT) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌